尿液抗原检测辅助诊断侵袭性曲霉病
研究优化了基于半乳呋喃糖特异性单克隆抗体mAb476的侧流试纸条法检测尿液抗原,在78例疑似侵袭性真菌感染受试者中验证。对确诊或临床诊断侵袭性曲霉病的每例敏感性和特异性分别为80%(95%CI 61.4%-92.3%)和92%(95%CI 74%-99%)。作者认为该尿液检测可作为高危患者诊断侵袭性曲霉病的辅助手段。
要点
- 尿液mAb476侧流试纸条检测诊断侵袭性曲霉病总体敏感性80%、特异性92%。
- 癌症亚组敏感性89.5%、特异性90.9%,非癌症组敏感性63.6%、特异性92.9%。
- 排除气道疾病肺移植受者后非癌症组敏感性升至85.7%。
核心结论
- 使用mAb476的尿液检测可作为高危患者诊断侵袭性曲霉病的辅助手段。
研究设计与样本
- 研究优化了基于半乳呋喃糖特异性单克隆抗体mAb476的侧流试纸条法,用于检测尿液抗原。
- 尿液样本来自78例接受疑似侵袭性真菌感染评估的受试者队列,样本冷冻保存至检测。
- 尿液经离心脱盐柱处理后暴露于试纸条,对临床诊断不知情的评审者进行结果分级。
- 对2例受试者尿液样本进行Western blot以表征mAb476反应性抗原。
主要发现
- 在总体队列中,诊断确诊或临床诊断侵袭性曲霉病的每例敏感性为80%(95%CI 61.4%-92.3%),特异性为92%(95%CI 74%-99%)。
- 在癌症亚组中,敏感性为89.5%(95%CI 66.7%-98.7%),特异性为90.9%(95%CI 58.7%-99.8%)。
- 在所有其他受试者中,敏感性和特异性分别为63.6%(95%CI 30.8%-89.1%)和92.9%(95%CI 66.1%-99.8%)。
- 排除有气道疾病的肺移植受者后,非癌症队列的敏感性增至85.7%(95%CI 42.1%-99.6%)。
- 半定量尿液检测结果与血清半乳甘露聚糖指数相关;Western blot显示病例尿液中的mAb476反应性抗原大小在26 kDa至35 kDa之间。
临床怎么用
- 作者认为,使用mAb476的尿液检测可作为高危患者诊断侵袭性曲霉病的辅助手段。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Establishing rapid diagnoses of invasive aspergillosis (IA) is a priority tests that detect galactomannan and β-d-glucan are available, but are technically cumbersome and rely on invasive sampling (blood or bronchoalveolar lavage). METHODS: We optimized a lateral flow dipstick assay using the galactofuranose-specific monoclonal antibody (mAb476), which recognizes urine antigens after Aspergillus fumigatus pulmonary infection in animals. Urine samples were obtained from a cohort of 78 subjects undergoing evaluation for suspected invasive fungal infections, and stored frozen until testing. Urine was processed by centrifugation through desalting columns and exposed to dipsticks. Reviewers blinded to clinical diagnoses graded results. Western blots were performed on urine samples from 2 subjects to characterize mAb476-reactive antigens. RESULTS: Per-patient sensitivity and specificity for diagnosis of proven or probable IA in the overall cohort was 80% (95% confidence interval [CI], 61.4%-92.3%) and 92% (95% CI, 74%-99%), respectively. In the subgroup with cancer, sensitivity was 89.5% (95% CI, 66.7%-98.7%) and specificity was 90.9% (95% CI, 58.7%-99.8%); among all others, sensitivity and specificity were 63.6% (95% CI, 30.8%-89.1%) and 92.9% (95% CI, 66.1%-99.8%), respectively. Eliminating lung transplant recipients with airway disease increased sensitivity in the noncancer cohort (85.7% [95% CI, 42.1%-99.6%]). Semiquantitative urine assay results correlated with serum galactomannan indices. Western blots demonstrated mAb476-reactive antigens in urine from cases, ranging between 26 kDa and 35 kDa in size. CONCLUSIONS: Urine testing using mAb476 may be used as an aid to diagnose IA in high-risk patients.
引用
- Marr KA, Datta K, Mehta S, et al. Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis. Clin Infect Dis. 2018. PMID: 29684106. doi:10.1093/cid/ciy326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。